|
|
Article: Reporting of laboratory-confirmed chlamydial infection and gonorrhea by providers affiliated with three large managed care organizations -- United States, 1995--1999.(Statistical Data Included)
- Article from:
- MMWR. Morbidity and Mortality Weekly Report
- Article date:
- March 29, 2002
CopyrightCOPYRIGHT 2002 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Surveillance for sexually transmitted diseases (STDs) depends on health departments receiving reports of positive STD test results from laboratories or of STD cases by clinicians (1). The completeness and timeliness of reporting can affect prompt sex partner notification and outbreak detection. In 1998, approximately 70% of chlamydia cases and 55% of gonorrhea cases were reported by private clinicians, including many affiliated with managed care organizations (MCOs) (2). However, little is known about the completeness and timeliness of MCOs' STD case reporting practices. Three MCOs, three state health departments, and CDC evaluated reporting practices for chlamydial ...
Related newspaper, magazine, and journal articles:
|
|
Article: Glycosaminoglycans protect against Chlamydia ...
Drug Week;
June 25, 2004 ;
700+ words
... ... U.S. and collaborators in the United States, France, and Israel. "We tested the ability of MAG to block chlamydia infection in vitro and in vivo. The MAG blocked infection of epithelial cells in vitro when added to the cells at the same ...
|
|